University Hematology Oncology, Inc

Centralia, Illinois 62801

We've found

1 trials

at this facility

NKTR-102 Versus Irinotecan in Patients With Second-Line, Irinotecan-Naïve, KRAS Mutant, Colorectal Cancer

Status: Enrolling, Phase II, III
Updated: 11/18/2013

from

Centralia, IL

Use our guide to learn which trials are right for you!